{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:38:36Z","timestamp":1792802316879,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.sleep.2026.109277","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:30:30Z","timestamp":1790098230000},"page":"109277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Solriamfetol for residual sleepiness and its impact on continuous positive airway pressure adherence: A French database analysis"],"prefix":"10.1016","volume":"149","author":[{"given":"Jean-Louis","family":"P\u00e9pin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9233-2288","authenticated-orcid":false,"given":"Karthik","family":"Maddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Arnaud-Pras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8844-3808","authenticated-orcid":false,"given":"Stephen","family":"Deacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6838-2680","authenticated-orcid":false,"given":"Stephane","family":"Bou\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4231-5102","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Gagnadoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2026.109277_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleep.2026.108777","article-title":"Sleep apnoea and its consequences: from animal models to precision medicine","volume":"140","author":"Heinzer","year":"2026","journal-title":"Sleep Med"},{"issue":"8","key":"10.1016\/j.sleep.2026.109277_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","article-title":"Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis","volume":"7","author":"Benjafield","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10.1016\/j.sleep.2026.109277_bib3","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S2213-2600(25)00243-7","article-title":"Projecting the 30-year burden of obstructive sleep apnoea in the USA: a prospective modelling study","volume":"13","author":"Boers","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.sleep.2026.109277_bib4","article-title":"Obstructive sleep apnoea syndrome","volume":"1","author":"L\u00e9vy","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.sleep.2026.109277_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S2213-2600(25)00002-5","article-title":"Positive airway pressure therapy and all-cause and cardiovascular mortality in people with obstructive sleep apnoea: a systematic review and meta-analysis of randomised controlled trials and confounder-adjusted, non-randomised controlled studies","volume":"13","author":"Benjafield","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.sleep.2026.109277_bib6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.sleep.2010.10.003","article-title":"Management of obstructive sleep apnea in Europe","volume":"12","author":"FietzeI","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2026.109277_bib7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/17476348.2023.2202853","article-title":"The individual and societal prices of non-adherence to continuous positive airway pressure, contributors, and strategies for improvement","volume":"17","author":"Mendelson","year":"2023","journal-title":"Expert Rev Respir Med"},{"issue":"5","key":"10.1016\/j.sleep.2026.109277_bib8","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/jcm10050936","article-title":"On behalf of the medXcloud group. CPAP therapy termination rates by OSA phenotype: a French nationwide database analysis","volume":"10","author":"P\u00e9pin","year":"2021","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.sleep.2026.109277_bib9","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.chest.2022.02.013","article-title":"Relationship between CPAP termination and all-cause mortality: a French nationwide database analysis","volume":"161","author":"P\u00e9pin","year":"2022","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.sleep.2026.109277_bib10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1513\/AnnalsATS.202208-738OC","article-title":"Dose-response relationship between obstructive sleep apnea therapy adherence and healthcare utilization","volume":"20","author":"Malhotra","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.sleep.2026.109277_bib11","article-title":"Healthcare resource utilisation and costs in patients with treated obstructive sleep apnea","author":"Sterling","year":"2023","journal-title":"J Sleep Res"},{"issue":"11","key":"10.1016\/j.sleep.2026.109277_bib12","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1164\/rccm.202202-0366OC","article-title":"Positive airway pressure adherence, mortality, and cardiovascular events in patients with sleep apnea","volume":"206","author":"Gerv\u00e8s-Pinqui\u00e9","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.sleep.2026.109277_bib13","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/thorax-2024-221689","article-title":"Association of positive airway pressure termination with mortality and non-fatal cardiovascular events in patients with obstructive sleep apnoea","volume":"79","author":"Sabil","year":"2024","journal-title":"Thorax"},{"key":"10.1016\/j.sleep.2026.109277_bib14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.sleep.2023.10.001","article-title":"Recommendations for clinical management of excessive daytime sleepiness in obstructive sleep apnoea - a Delphi consensus study","volume":"112","author":"Steier","year":"2023","journal-title":"Sleep Med"},{"issue":"164","key":"10.1016\/j.sleep.2026.109277_bib15","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0230-2021","article-title":"Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view","volume":"31","author":"Craig","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"7","key":"10.1016\/j.sleep.2026.109277_bib17","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/00325481.2021.1948305","article-title":"Residual excessive daytime sleepiness in patients treated for obstructive sleep apnea: guidance for assessment, diagnosis, and management","volume":"133","author":"Rosenberg","year":"2021","journal-title":"Postgrad Med J"},{"issue":"5","key":"10.1016\/j.sleep.2026.109277_bib18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.7326\/M22-3473","article-title":"Comparative efficacy and safety of wakefulness-promoting agents for excessive daytime sleepiness in patients with obstructive sleep apnea: a systematic review and network meta-analysis","volume":"176","author":"Pitre","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.sleep.2026.109277_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102843","article-title":"Comparative efficacy, safety and benefit\/risk of alerting agents for excessive daytime sleepiness in patients with obstructive sleep apnoea: a network meta-analysis","volume":"76","author":"P\u00e9pin","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"Suppl 4","key":"10.1016\/j.sleep.2026.109277_bib20","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: from the syst\u00e8me national d'information interr\u00e9gimes de l'Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"24","key":"10.1016\/j.sleep.2026.109277_bib21","first-page":"S0300","article-title":"National implementation of CPAP telemonitoring and a pay-for-performance scheme for homecare providers in France leads to prioritisation of resources to individuals with low therapy adherence: the IMPACT-PAP cohort study","volume":"21","author":"Texereau","year":"2024","journal-title":"Arch Bronconeumol"},{"issue":"2","key":"10.1016\/j.sleep.2026.109277_bib22","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01171-2023","article-title":"CPAP resumption after a first termination and impact on all-cause mortality in France","volume":"63","author":"P\u00e9pin","year":"2024","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.sleep.2026.109277_bib23","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1164\/ajrccm.164.9.2103032","article-title":"Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea","volume":"164","author":"Pack","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.sleep.2026.109277_bib24","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1378\/chest.13-0179","article-title":"CPAP improves endothelial function in patients with minimally symptomatic OSA: results from a subset study of the MOSAIC trial","volume":"144","author":"Kohler","year":"2013","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.sleep.2026.109277_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.chest.2021.02.033","article-title":"Randomized controlled trial of solriamfetol for excessive daytime sleepiness in OSA: an analysis of subgroups adherent or nonadherent to OSA treatment","volume":"160","author":"Schweitzer","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.sleep.2026.109277_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleep.2025.106706","article-title":"Solriamfetol for the treatment of excessive daytime sleepiness in participants with obstructive sleep apnea with different levels of adherence to primary OSA therapy: subgroup analysis of a randomized clinical trial","volume":"134","author":"Shen","year":"2025","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.sleep.2026.109277_bib27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.5664\/jcsm.8992","article-title":"Effects of solriamfetol in a long-term trial of participants with obstructive sleep apnea who are adherent or nonadherent to airway therapy","volume":"17","author":"Schweitzer","year":"2021","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"10.1016\/j.sleep.2026.109277_bib28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s40120-021-00289-6","article-title":"Current management of residual excessive daytime sleepiness due to obstructive sleep apnea: insights for optimizing patient outcomes","volume":"10","author":"Mehra","year":"2021","journal-title":"Neurol Ther"},{"issue":"1","key":"10.1016\/j.sleep.2026.109277_bib30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s44470-025-00022-2","article-title":"Real-world effectiveness and tolerability of wake-promoting agents for residual sleepiness in treated obstructive sleep apnea","volume":"22","author":"Roberts","year":"2026","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"10.1016\/j.sleep.2026.109277_bib31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.5664\/jcsm.9006","article-title":"Clinically relevant effects of solriamfetol on excessive daytime sleepiness: a posthoc analysis of the magnitude of change in clinical trials in adults with narcolepsy or obstructive sleep apnea","volume":"17","author":"Rosenberg","year":"2021","journal-title":"J Clin Sleep Med"},{"issue":"Supplement_1","key":"10.1016\/j.sleep.2026.109277_bib32","doi-asserted-by":"crossref","first-page":"A340","DOI":"10.1093\/sleep\/zsaf090.0786","article-title":"Real-world use of solriamfetol for excessive daytime sleepiness in patients with obstructive sleep apnea in the US","volume":"48","author":"Zhao","year":"2025","journal-title":"Sleep"},{"issue":"11","key":"10.1016\/j.sleep.2026.109277_bib33","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1164\/rccm.201806-1100OC","article-title":"TONES 3 study investigators. Solriamfetol for excessive sleepiness in obstructive sleep apnea (TONES 3). A randomized controlled trial","volume":"199","author":"Schweitzer","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.sleep.2026.109277_bib34","doi-asserted-by":"crossref","DOI":"10.2196\/65840","article-title":"Evaluating the benefit of home support provider services for positive airway pressure therapy in patients with obstructive sleep apnea: protocol for an ambispective international real-world study","volume":"14","author":"Alami","year":"2025","journal-title":"JMIR Res Protoc"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945726005162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945726005162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:08:37Z","timestamp":1792800517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945726005162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":32,"alternative-id":["S1389945726005162"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2026.109277","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Solriamfetol for residual sleepiness and its impact on continuous positive airway pressure adherence: A French database analysis","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2026.109277","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109277"}}